Dasatinib as a Bone-Modifying Agent: Anabolic and Anti-Resorptive EffectsAntonio García-Gómez, Mercedes Garayoa|PLoS ONE|2012Cited by 78
Targeting aberrant DNA methylation in mesenchymal stromal cells as a treatment for myeloma bone diseaseAntonio García-Gómez, Esteban Ballestar|Nature Communications|2021Cited by 54